Stock Screener App

Gratuito -

Installare

0.6127

4.41% -0.0283

Lyell Immunopharma Inc (LYEL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Lyell Immunopharma Inc Azioni (LYEL) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	76.92% 0.003	0.013	0.025	0.027	0.065
Operating Expenses	6.62% 55.58	59.52	59.06	65.93	62.62
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	6.62% 55.58	59.52	59.06	65.93	62.62
Operating Income/Loss	6.61% -55.58	-59.51	-59.04	-65.91	-62.56
Nonoperating Income/Loss	177.41% -5.092	6.578	8.186	2.015	-4.403
Income/Loss From Continuing Operations Before Tax	76.92% 0.003	0.013	0.025	0.027	0.065
Income/Loss From Continuing Operations After Tax	14.62% -60.67	-52.93	-50.85	-63.89	-66.96
Net Income/Loss	14.62% -60.67	-52.93	-50.85	-63.89	-66.96
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	41,856% 254.25	0.606	251.32	250.20	249.59
Diluted Average Shares	41,856% 254.25	0.606	251.32	250.20	249.59
Basic Earnings Per Share	20.00% -0.24	-0.20	-0.20	-0.26	-0.27
Diluted Earnings Per Share	20.00% -0.24	-0.20	-0.20	-0.26	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters